Post-approval studies (Phase 4)Study completedNCT00546442What this trial is testingTreatment Insulin Resistence in HCV G-1 PatientWho this might be right forChronic Hepatitis C Valme University Hospital 126
Large-scale testing (Phase 3)Study completedNCT00502086What this trial is testingEfficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.Who this might be right forCirrhosisChronic Hepatitis C Catalysis SL 100
Post-approval studies (Phase 4)Active Not RecruitingNCT05140941What this trial is testingSofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During PregnancyWho this might be right forHepatitis C, ChronicPregnancy; Infection Catherine Anne Chappell 100
Large-scale testing (Phase 3)Ended earlyNCT02465203What this trial is testing3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir StudyWho this might be right forHepatitis C, Chronic Novartis Pharmaceuticals 105
Not applicableUnknownNCT04061551What this trial is testingEliminate Hepatitis C/EC Partnership Evaluation ProtocolWho this might be right forHepatitis CChronic Hepatitis cHepatitis C, Chronic Macfarlane Burnet Institute for Medical Research and Public Health Ltd 25
Not applicableUnknownNCT03551002What this trial is testingImpact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San DiegoWho this might be right forHepatitis CHepatitis C, ChronicHIV/AIDS University of California, San Diego 450
Post-approval studies (Phase 4)WithdrawnNCT04614142What this trial is testingSingle Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis AccessWho this might be right forEnd Stage Renal DiseaseChronic Hepatitis c Massachusetts General Hospital
Not applicableStudy completedNCT01310205What this trial is testingExtension Study SCI-SCV-HCV-P2-001: Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Completing Treatment in HCVWho this might be right forChronic Hepatitis C SciClone Pharmaceuticals 12
Post-approval studies (Phase 4)Study completedNCT02461745What this trial is testingReal World Study: Genotype 1 Chronic Hepatitis C Virus Treatment and Evaluation of Real World SVR and PROWho this might be right forHepatitis C, Chronic Kaiser Permanente 200
Testing effectiveness (Phase 2)Study completedNCT02336139What this trial is testingA Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug UseWho this might be right forHepatitis C Kirby Institute 103
Large-scale testing (Phase 3)Study completedNCT00299936What this trial is testingComparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve SubjectsWho this might be right forChronic Hepatitis C Weill Medical College of Cornell University 5,000
Not applicableStudy completedNCT00725205What this trial is testingPatient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690)Who this might be right forHepatitis C, ChronicHepatitis C Merck Sharp & Dohme LLC 294
Early research (Phase 1)Study completedNCT01448200What this trial is testingPPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1Who this might be right forHepatitis C, Chronic Presidio Pharmaceuticals, Inc. 82
Not applicableStudy completedNCT04214028What this trial is testingThe Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C VirusWho this might be right forHepatitis C Virus (HCV) AbbVie 50
Large-scale testing (Phase 3)UnknownNCT01623336What this trial is testingBIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis CWho this might be right forChronic Hepatitis C The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 740
Large-scale testing (Phase 3)Study completedNCT00623428What this trial is testingCombination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral ResponseWho this might be right forHepatitis C, Chronic Hoffmann-La Roche 235
Not applicableWithdrawnNCT01813266What this trial is testingProspective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk FactorsWho this might be right forChronic Hepatitis C Virus Infection Intermountain Health Care, Inc.
Early research (Phase 1)WithdrawnNCT00449124What this trial is testingTG4040 in Patients With Chronic HCVWho this might be right forHepatitis C National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT03490097What this trial is testingStatins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir CombinationWho this might be right forChronic Hepatitis cMetabolic Syndrome Ain Shams University 100
Not applicableStudy completedNCT02557646What this trial is testingAn Observational Study to Assess the Effect of Cumulative Ribavirin Dose in Participants With Chronic Hepatitis CWho this might be right forHepatitis C, Chronic Hoffmann-La Roche 697